Loading company details...
Beta
Latest Form 4 (Oct 4, 2024): Scott Mendel (Director): Grant/Award of 44,959 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 4, 2024 | Scott Mendel | Grant/Award | 44,959 | n/a |
| Sep 3, 2024 | Pascal Bamford, Chief Clinical Officer | Grant/Award | 40,000 | n/a |
| Jun 12, 2024 | Brian McKelligon, President and CEO | Exercise/Conversion | 7,500 | $2.3K |
| Jun 7, 2024 | Brian McKelligon, President and CEO | Exercise/Conversion | 7,500 | $2.3K |
| Jun 5, 2024 | Thomas A. Raffin | Grant/Award | 50,000 | n/a |
| Jun 5, 2024 | Robert G. Shepler | Grant/Award | 50,000 | n/a |
| Jun 5, 2024 | Matthew Winkler | Grant/Award | 50,000 | n/a |
| Jun 5, 2024 | Thomas P. Schnettler | Grant/Award | 50,000 | n/a |
| Jun 5, 2024 | Goldman Myla Lai | Grant/Award | 50,000 | n/a |
| Jun 5, 2024 | Scott Mendel | Grant/Award | 50,000 | n/a |